Dr. Jeff Lombardo, PharmD, BCOP, Research Assistant Professor, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
discusses chemotherapy compounding, related safety issues, and the advantages of INFUGEM™ (gemcitabine hydrochloride in 0.9% sodium chloride injection).
Related Items
JHOP - April 2023 Vol 13, No 2 published on April 25, 2023 in Practical Issues in Pharmacy Management
JHOP - February 2022 Vol 12, No 1 published on March 1, 2022 in Original Article, Chemotherapy, Practical Issues in Pharmacy Management